The NeurologyLive® neuromuscular disease clinical focus page offers updates and information related to the clinical care and management of individuals with neuromuscular diseases such as amyotrophic lateral sclerosis, Duchenne muscular dystrophy, cerebral palsy, and spinal muscular atrophy, as well as rare diseases. This page consists of news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, study and clinical trial findings, and more.

Latest News

Investigational PrimeC Improves Complication-Free Survival in PARADIGM Study of ALS
Investigational PrimeC Improves Complication-Free Survival in PARADIGM Study of ALS

July 13th 2024

Following the positive data, NeuroSense intends to submit 12-month results to the FDA for regulatory discussions on future path.

NeurologyLive® Friday 5 — July 12, 2024
NeurologyLive® Friday 5 — July 12, 2024

July 12th 2024

Riliprubart Continues to Show Pronounced Impacts on CIDP at 1 Year
Riliprubart Continues to Show Pronounced Impacts on CIDP at 1 Year

July 10th 2024

Capricor to Meet With FDA Following Positive 3-Year Data on Duchenne Agent CAP-1002
Capricor to Meet With FDA Following Positive 3-Year Data on Duchenne Agent CAP-1002

July 9th 2024

FDA Action Update, June 2024: Approvals, Designation, and Clearance
FDA Action Update, June 2024: Approvals, Designation, and Clearance

July 8th 2024

Latest CME Events & Activities

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, ...

September 15, 2024

Register Now!

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

October 16, 2024

Register Now!

Mastering MS: Translating Evidence into Optimal Management Plans

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

View More

Burst CME: Optimizing Therapy in Parkinson’s Disease

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.